glp-1 receptor agonists blindness risk Ocular Effects of Agonists: A Review of Current Evidence and Safety Concerns Frontiers | GLP-1 Receptor Agonists:

You'll also get the latest articles directly to your inbox

In a recent clinical study, individuals with heart failure and preserved ejection fraction who received weekly semaglutide injections (2.4 mg) for 52 weeks experienced substantially improved symptoms and physical function compared to the placebo group 9

GLP-1 (glucagon-like peptide-1) receptor agonists work by helping regulate appetite, slow digestion, and support blood sugar balance

Some patients who tolerate once-weekly injectable GLP-1s may find daily oral GI exposure more difficult, or vice versa

Yong Xu, Affiliated Hospital of Southwest Medical University, China Updates Copyright 2020 Kawanami and Takashi

Although rates of adverse effects differ between specific agents, the most common adverse effects with the GLP- 1 RA class are gastrointestinal (GI)related